NO20042433L - Syntese og rensing av valasyklovir - Google Patents
Syntese og rensing av valasyklovirInfo
- Publication number
- NO20042433L NO20042433L NO20042433A NO20042433A NO20042433L NO 20042433 L NO20042433 L NO 20042433L NO 20042433 A NO20042433 A NO 20042433A NO 20042433 A NO20042433 A NO 20042433A NO 20042433 L NO20042433 L NO 20042433L
- Authority
- NO
- Norway
- Prior art keywords
- valasyclovir
- purification
- synthesis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33280201P | 2001-11-14 | 2001-11-14 | |
US34227301P | 2001-12-21 | 2001-12-21 | |
PCT/US2002/036269 WO2003041647A2 (en) | 2001-11-14 | 2002-11-13 | Synthesis and purification of valacyclovir |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20042433L true NO20042433L (no) | 2004-07-22 |
Family
ID=26988392
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20042433A NO20042433L (no) | 2001-11-14 | 2004-06-11 | Syntese og rensing av valasyklovir |
Country Status (14)
Country | Link |
---|---|
US (2) | US6849737B2 (no) |
EP (1) | EP1465894A4 (no) |
JP (1) | JP2005508993A (no) |
KR (2) | KR20070020149A (no) |
CN (1) | CN1307177C (no) |
CA (2) | CA2649826A1 (no) |
HR (1) | HRP20040511A2 (no) |
IL (1) | IL161969A0 (no) |
IN (1) | IN2007DE04250A (no) |
IS (1) | IS7260A (no) |
MX (1) | MX242714B (no) |
NO (1) | NO20042433L (no) |
PL (1) | PL371732A1 (no) |
WO (1) | WO2003041647A2 (no) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1436295A4 (en) * | 2001-09-07 | 2007-07-11 | Teva Pharma | CRISTALLINE FORMS OF VALACYCLOVIR HYDROCHLORIDE |
JP2005511612A (ja) * | 2001-11-05 | 2005-04-28 | グラクソ グループ リミテッド | 塩酸バラシクロビルの無水結晶形 |
KR20070020149A (ko) * | 2001-11-14 | 2007-02-16 | 테바 파마슈티컬 인더스트리즈 리미티드 | 발라시클로비르의 합성 및 정제 방법 |
US20050043329A1 (en) * | 2002-09-06 | 2005-02-24 | Shlomit Wizel | Crystalline forms of valacyclovir hydrochloride |
US20050059684A1 (en) * | 2002-10-16 | 2005-03-17 | Ben-Zion Dolitzky | Method for reducing residual alcohols in crystalline valacyclovir hydrochloride |
EP1551838B1 (en) * | 2002-10-16 | 2006-08-09 | Teva Pharmaceutical Industries Ltd. | Method for reducing residual alcohols in crystalline valacyclovir hydrochloride |
CA2548608A1 (en) * | 2002-12-09 | 2004-06-24 | Texcontor Etablissement | Anhydrous crystalline form of valacyclovir hydrochloride |
WO2004106338A1 (en) * | 2003-05-30 | 2004-12-09 | Eos Eczacibasi Ozgun Kimyasal Urunler Sanayi Ve Ticaret A.S. | Novel crystalline forms of valacyclovir hydrochloride |
TW200510414A (en) * | 2003-06-02 | 2005-03-16 | Teva Pharma | Novel crystalline forms of valacyclovir hydrochloride |
KR20060117355A (ko) * | 2004-01-21 | 2006-11-16 | 테바 파마슈티컬 인더스트리즈 리미티드 | 발라시클로버 염산염의 제조 방법 |
CN1976933A (zh) * | 2004-06-30 | 2007-06-06 | 特瓦制药工业有限公司 | 减少晶体盐酸伐昔洛韦中的残留醇的方法 |
KR100890595B1 (ko) | 2004-09-04 | 2009-03-25 | 테바 파마슈티컬 인더스트리즈 리미티드 | 단리된 발라시클로버 불순물, 발라시클로버 불순물 제조방법 및 참조 표준 물질로서의 용도 |
US7958087B2 (en) * | 2004-11-17 | 2011-06-07 | Iron Mountain Incorporated | Systems and methods for cross-system digital asset tag propagation |
EP1746098A1 (en) * | 2005-07-21 | 2007-01-24 | SOLMAG S.p.A. | Valacyclovir polymorphs and a process for the preparation thereof |
US20070112193A1 (en) * | 2005-11-14 | 2007-05-17 | Khunt Mayur D | Valacyclovir process |
GB0605344D0 (en) * | 2006-03-17 | 2006-04-26 | Pliva Istrazivanje I Razvoj D | Pharmaceutically acceptable salts and polymorphic forms |
CN1903854B (zh) * | 2006-08-09 | 2012-05-23 | 丽珠医药集团股份有限公司 | 一种合成盐酸伐昔洛韦的方法 |
WO2008139539A1 (ja) * | 2007-04-27 | 2008-11-20 | Ajinomoto Co., Inc. | バラシクロビルの製造方法 |
US20080281099A1 (en) * | 2007-05-07 | 2008-11-13 | Mayur Devjibhai Khunt | Process for purifying valacyclovir hydrochloride and intermediates thereof |
CN102584825B (zh) * | 2011-01-17 | 2014-04-02 | 四川科伦药物研究有限公司 | 一种合成盐酸伐昔洛韦的方法 |
WO2017149420A1 (en) * | 2016-03-03 | 2017-09-08 | Aurobindo Pharma Ltd | Process for the preparation of valacyclovir |
CN106632335A (zh) * | 2016-12-27 | 2017-05-10 | 河南康达制药有限公司 | 一种盐酸伐昔洛韦的制备方法 |
CN114621227A (zh) * | 2022-02-28 | 2022-06-14 | 海南久常制药有限公司 | 一种盐酸伐昔洛韦、制剂及其制备方法 |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4199574A (en) | 1974-09-02 | 1980-04-22 | Burroughs Wellcome Co. | Methods and compositions for treating viral infections and guanine acyclic nucleosides |
GB8719367D0 (en) | 1987-08-15 | 1987-09-23 | Wellcome Found | Therapeutic compounds |
ES2157259T3 (es) * | 1993-06-10 | 2001-08-16 | Rolabo Sl | Procedimiento para preparar esteres de aminoacidos y analogos de nucleosidos. |
GB9501178D0 (en) * | 1995-01-20 | 1995-03-08 | Wellcome Found | Guanine derivative |
GB9501127D0 (en) * | 1995-01-20 | 1995-03-08 | Wellcome Found | Tablet |
US6117453A (en) * | 1995-04-14 | 2000-09-12 | Pharma Pass | Solid compositions containing polyethylene oxide and an active ingredient |
US5672243A (en) * | 1995-11-28 | 1997-09-30 | Mosel Vitelic, Inc. | Antireflection coating for highly reflective photolithographic layers comprising chromium oxide or chromium suboxide |
AU722304B2 (en) * | 1996-01-19 | 2000-07-27 | Glaxo Group Limited | Use of valaciclovir for the manufacture of a medicament for the treatment of genital herpes by a single daily application |
US5756736A (en) * | 1996-01-26 | 1998-05-26 | Syntex (U.S.A.) Inc. | Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative |
US6040446A (en) * | 1996-01-26 | 2000-03-21 | Syntex (U.S.A.) Inc. | Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol derivative |
IT1283447B1 (it) * | 1996-07-18 | 1998-04-21 | Ind Chimica Srl | Processo di preparazione del valaciclovir e relativi intermedi |
KR20000053226A (ko) * | 1996-11-12 | 2000-08-25 | 요나스 프릭 | 뉴클레오사이드 |
EP1436295A4 (en) * | 2001-09-07 | 2007-07-11 | Teva Pharma | CRISTALLINE FORMS OF VALACYCLOVIR HYDROCHLORIDE |
JP2005511612A (ja) * | 2001-11-05 | 2005-04-28 | グラクソ グループ リミテッド | 塩酸バラシクロビルの無水結晶形 |
KR20070020149A (ko) * | 2001-11-14 | 2007-02-16 | 테바 파마슈티컬 인더스트리즈 리미티드 | 발라시클로비르의 합성 및 정제 방법 |
AU2003240213A1 (en) * | 2002-06-24 | 2004-01-06 | Ranbaxy Laboratories Limited | Process for the preparation of robust formulations of valacyclovir hydrochloride tablets |
US20050043329A1 (en) * | 2002-09-06 | 2005-02-24 | Shlomit Wizel | Crystalline forms of valacyclovir hydrochloride |
EP1551838B1 (en) * | 2002-10-16 | 2006-08-09 | Teva Pharmaceutical Industries Ltd. | Method for reducing residual alcohols in crystalline valacyclovir hydrochloride |
US20050059684A1 (en) * | 2002-10-16 | 2005-03-17 | Ben-Zion Dolitzky | Method for reducing residual alcohols in crystalline valacyclovir hydrochloride |
CA2548608A1 (en) * | 2002-12-09 | 2004-06-24 | Texcontor Etablissement | Anhydrous crystalline form of valacyclovir hydrochloride |
WO2004106338A1 (en) * | 2003-05-30 | 2004-12-09 | Eos Eczacibasi Ozgun Kimyasal Urunler Sanayi Ve Ticaret A.S. | Novel crystalline forms of valacyclovir hydrochloride |
TW200510414A (en) * | 2003-06-02 | 2005-03-16 | Teva Pharma | Novel crystalline forms of valacyclovir hydrochloride |
KR20060117355A (ko) * | 2004-01-21 | 2006-11-16 | 테바 파마슈티컬 인더스트리즈 리미티드 | 발라시클로버 염산염의 제조 방법 |
US20060178512A1 (en) * | 2005-02-04 | 2006-08-10 | Cheruthur Govindan | Method for preparing amino acid esters of nucleoside analogues |
EP1746098A1 (en) * | 2005-07-21 | 2007-01-24 | SOLMAG S.p.A. | Valacyclovir polymorphs and a process for the preparation thereof |
US20070112193A1 (en) * | 2005-11-14 | 2007-05-17 | Khunt Mayur D | Valacyclovir process |
US20080281099A1 (en) * | 2007-05-07 | 2008-11-13 | Mayur Devjibhai Khunt | Process for purifying valacyclovir hydrochloride and intermediates thereof |
-
2002
- 2002-11-13 KR KR1020077002062A patent/KR20070020149A/ko not_active Application Discontinuation
- 2002-11-13 MX MXPA04004656 patent/MX242714B/es active IP Right Grant
- 2002-11-13 JP JP2003543534A patent/JP2005508993A/ja not_active Withdrawn
- 2002-11-13 WO PCT/US2002/036269 patent/WO2003041647A2/en active Application Filing
- 2002-11-13 IL IL16196902A patent/IL161969A0/xx unknown
- 2002-11-13 EP EP02793918A patent/EP1465894A4/en not_active Withdrawn
- 2002-11-13 PL PL02371732A patent/PL371732A1/xx not_active Application Discontinuation
- 2002-11-13 CA CA002649826A patent/CA2649826A1/en not_active Abandoned
- 2002-11-13 CA CA002465928A patent/CA2465928C/en not_active Expired - Fee Related
- 2002-11-13 CN CNB028268970A patent/CN1307177C/zh not_active Expired - Fee Related
- 2002-11-13 KR KR1020047007289A patent/KR20050044449A/ko active Search and Examination
- 2002-11-13 US US10/293,347 patent/US6849737B2/en not_active Expired - Fee Related
-
2004
- 2004-05-11 IS IS7260A patent/IS7260A/is unknown
- 2004-06-07 HR HR20040511A patent/HRP20040511A2/hr not_active Application Discontinuation
- 2004-06-11 NO NO20042433A patent/NO20042433L/no not_active Application Discontinuation
-
2005
- 2005-01-25 US US11/042,538 patent/US20050130993A1/en not_active Abandoned
-
2007
- 2007-06-05 IN IN4250DE2007 patent/IN2007DE04250A/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA2649826A1 (en) | 2003-05-22 |
HRP20040511A2 (en) | 2004-10-31 |
WO2003041647A3 (en) | 2003-11-20 |
CN1612878A (zh) | 2005-05-04 |
IN2007DE04250A (no) | 2007-08-31 |
IL161969A0 (en) | 2005-11-20 |
IS7260A (is) | 2004-05-11 |
MXPA04004656A (es) | 2004-08-13 |
CA2465928A1 (en) | 2003-05-22 |
EP1465894A4 (en) | 2008-10-08 |
MX242714B (es) | 2006-12-15 |
PL371732A1 (en) | 2005-06-27 |
KR20050044449A (ko) | 2005-05-12 |
EP1465894A2 (en) | 2004-10-13 |
CA2465928C (en) | 2010-01-19 |
KR20070020149A (ko) | 2007-02-16 |
JP2005508993A (ja) | 2005-04-07 |
US20050130993A1 (en) | 2005-06-16 |
CN1307177C (zh) | 2007-03-28 |
WO2003041647A2 (en) | 2003-05-22 |
US6849737B2 (en) | 2005-02-01 |
US20030153757A1 (en) | 2003-08-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20042433L (no) | Syntese og rensing av valasyklovir | |
IS7344A (is) | Stýrð efnasmíði síprasídóns og samsetninga af því | |
NO20025318D0 (no) | FremgangsmÕte for rensing av syntesegass | |
NO20041582L (no) | Antistoffinhibitorer av GDF-8 og anvendelse derav | |
NO20033387D0 (no) | Modifiserte antistoffer og fremgangsmåter for anvendelse | |
NO20030725D0 (no) | Terapeutisk kombinasjon av CETP-inhibitor og atorvastatin | |
NO20041975L (no) | Bicyklisk oksopyridin og oksopyrimidinderivater | |
NO20042185L (no) | Kromatografisk rensing av rekombinant humant erytropoietin | |
NO20040390L (no) | Krystallinske former VI og VII av atorvastatinkalsium. | |
IS7467A (is) | Lansóprasólfjölgervingar og aðferðir við að framleiða þá | |
NO20033854D0 (no) | N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse | |
NO20033259L (no) | Fremgangsmåte for rensing av höyere diamantoider og materialer omfattende slike diamantoider | |
NO20011026D0 (no) | Matvare og fremgangsmÕte for fremstilling derav | |
NO20033323L (no) | Effektregulering av samband med tale og generelle data | |
NO20040887L (no) | Rensing og krystallinske former av zaleplon. | |
DK2305689T3 (da) | Syntese af naturligt forekommende ecteinascidiner og relateredeforbindelser | |
NO20041968L (no) | Anvendelse av cystationin | |
NO20040368L (no) | Fremgangsmate til fremstilling og rensing av natriumhydrid | |
NO20031739L (no) | Fremgangsmåte for rensing av pravastatin | |
NO20034531D0 (no) | Brönnbetjeningsfluid og fremgangsmåte for fremstilling og anvendelse av dette | |
DK1372652T3 (da) | Kombination af docetaxel og flavopiridol | |
NO20042126L (no) | Syntese av 2-aralkoksyadenosiner og 2-alkoksyadenosiner | |
NO20033743D0 (no) | Fremgangsmåte og fremstilling citalopram | |
NO20031197D0 (no) | Rensing av naturlige hydrokarboner | |
NO20034972L (no) | Behandling av ADHD |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |